Global Monocyte Activation Test Market Analysis (2026–2030) With Strategic Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Monocyte Activation Test Market Grow Between 2026 And 2030?

The monocyte activation test market has demonstrated substantial growth in recent years. This market is forecasted to increase from $0.54 billion in 2025 to $0.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.9%. The expansion observed in prior periods stems from various factors, such as the rise in biologics development initiatives, increased regulatory oversight regarding pyrogen safety, the adoption of non-animal based testing alternatives, the broadening of pharmaceutical quality control testing, and greater investment in in vitro testing innovations.

The monocyte activation test market is anticipated to experience significant expansion in the upcoming years. It is projected to reach a value of $1.08 billion by 2030, progressing at a compound annual growth rate (CAGR) of 14.6%. This expected growth during the forecast period stems from factors such as the increasing embrace of advanced biologics and vaccines, a surging demand for high-throughput safety testing, the proliferation of automated laboratory workflows, expanding regulatory endorsement for animal-free testing, and the greater integration of digital lab platforms. Prominent trends observed during this period include the rising adoption of animal-free pyrogen testing, an increase in the utilization of automated MAT assay systems, the growing incorporation of data management software, the enlargement of GMP-compliant testing solutions, and an intensified focus on securing regulatory acceptance of MAT.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24610&type=smp

What Leading Drivers Are Supporting The Monocyte Activation Test Market Expansion?

The increasing prevalence of autoimmune disorders is anticipated to drive expansion in the monocyte activation test market. Autoimmune conditions occur when the body’s immune system mistakenly targets its own healthy cells, tissues, or organs, rather than safeguarding against infections and foreign substances. The escalating incidence of these disorders is largely attributed to greater exposure to pollutants, which can disrupt immune regulation and provoke abnormal responses. The monocyte activation test (MAT) assists in identifying autoimmune disorders by offering a reliable method to assess immune system activation. This test helps pinpoint irregular immune responses, which is vital for diagnosing conditions like lupus and rheumatoid arthritis, thereby enhancing early detection and treatment of these ailments. For example, in February 2024, Arthritis Australia, an Australia-based non-profit organization, estimated that 562,378 Australians would be living with RA in 2025, constituting 14% of all arthritis cases that year. By 2040, this figure is projected to increase by 33% to 748,721 people, representing an additional 186,343 Australians with RA compared with 2025. Consequently, the rising occurrence of autoimmune disorders is stimulating growth in the monocyte activation test market. The escalating occurrence of healthcare-associated infections is expected to propel the expansion of the monocyte activation test market in the future. Healthcare-associated infections are illnesses that patients contract while receiving medical care within a healthcare facility. The surge in these infections is driven by the increased use of invasive medical devices, which can introduce germs into the body and elevate the risk of infection. The monocyte activation test helps tackle healthcare-associated infections by identifying pyrogens at an early stage, thereby facilitating safer medical devices and injectable products that diminish the risk of complications related to infection. For instance, in January 2025, the National Library of Medicine, a US-based organization dedicated to collecting and providing access to extensive biomedical literature and data, reported that out of 13,654 patients in 218 hospitals, 357 (2.6%) had 392 HAIs. Patients with HAIs were more frequently found in large hospitals and critical care units compared to those without an HAI. Therefore, the growing incidence of healthcare-associated infections is fueling the growth of the monocyte activation test market.

How Is The Monocyte Activation Test Market Broken Down By Segment Categories?

The monocyte activation test market covered in this report is segmented –

1) By Product Type: Reagents, Test Kits, Assay Systems, Software Solutions

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Polymerase Chain Reaction (PCR), Luminex Technologies

3) By Distribution Channel: Direct Sales, Distributors Or Third-party Partners, Online Retailers, Institutional Sales

4) By Application: Drug Development, Vaccine Development, Medical Device Testing, Other Applications

5) By End-User: Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Hospitals And Laboratories

Subsegments:

1) By Reagents: Endotoxin Standards, Cytokine Detection Reagents, Cell Culture Media, Limulus Amebocyte Lysate (LAL) Reagents, Blocking Agents And Buffers

2) By Test Kits: Quantitative Monocyte Activation Test Kits, Qualitative Monocyte Activation Test Kits, Good Manufacturing Practice (GMP)-Compliant Test Kits, Endotoxin-Specific Test Kits, Pyrogen Detection Kits

3) By Assay Systems: Benchtop Monocyte Activation Analyzers, Automated High-Throughput Systems, Microplate Readers, Cell Imaging Systems, Flow Cytometry-Based Systems

4) By Software Solutions: Data Analysis Software, Laboratory Information Management Systems (LIMS) Integration Tools, Compliance And Audit Trail Software, Remote Monitoring And Control Software, Real-Time Result Interpretation Tools

What Emerging Trends Are Seen In The Monocyte Activation Test Market?

Major companies in the monocyte activation test market are focusing on developing technologically advanced monocyte activation test (MAT) products, such as pyrogen and endotoxin tests, to heighten test sensitivity and improve the identification of immune responses. Pyrogen and endotoxin tests are utilized to detect substances that induce fever, especially endotoxins from gram-negative bacteria. For instance, in June 2024, FUJIFILM Wako Pure Chemicals Corporation, a Japan-based chemical manufacturer, introduced the LumiMAT Pyrogen Detection Kit, a next-generation monocyte activation test for in vitro pyrogen screening, and PYROSTAR Neo+, a recombinant protein reagent for bacterial endotoxin detection. These products collectively improve the accuracy, efficiency, and safety of pyrogen testing within the pharmaceutical and biotechnology industries.

Which Players Are Present In The Monocyte Activation Test Market Space?

Major companies operating in the monocyte activation test market are Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Lonza Group, Charles River Laboratories, Nelson Laboratories LLC, Solvias AG, Labor LS SE and Co. KG, BMG Labtech, Cellular Technology Limited, Creative Biolabs, FUJIFILM Wako Chemicals, Microcoat Biotechnologie GmbH, MAT BioTech B.V., Sanquin Diagnostiek B.V., PyroDex LLC, MAT Research B.V., Minerva Biolabs GmbH, Wickham Micro Limited, Rapid Test Methods Ltd.

Get The Full Monocyte Activation Test Market Report:

https://www.thebusinessresearchcompany.com/report/monocyte-activation-test-global-market-report

Where Is The Monocyte Activation Test Market Primarily Concentrated By Region?

North America was the largest region in the monocyte activation test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monocyte activation test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Monocyte Activation Test Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/monocyte-activation-test-global-market-report

Browse Through More Reports Similar to the Global Monocyte Activation Test Market 2026, By The Business Research Company

Monkey Pox Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Zoonotic Disease Treatment Market Report

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Sheep And Goat Pox Vaccines Market Report

https://www.thebusinessresearchcompany.com/report/sheep-and-goat-pox-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795